发布网友 发布时间:2022-05-29 18:12
共5个回答
热心网友 时间:2023-11-01 11:26
[摘要] Abstract热心网友 时间:2023-11-01 11:27
[Abstract] Objective: Through the use of analysis of the situation in 33 hospitals in Nanjing from 2009 to 2011 antifungal, evaluation in recent years antifungal therapy. Methods: The amount and frequency of drug analysis and sorting method for drug utilization analysis. Results: 1) antifungal agents accounted for the total amount of antimicrobial drugs was increasing year by year, of which 2010 the average annual growth rate up to 16.9%. 2) of the amount of antifungal agents than is deep antimicrobial agents, especially triazole drugs, the amount of 33.6056 million yuan in 2009 to 44.1843 million yuan in 2011, the average annual growth rate of 14.66%, the spines white mold The average annual growth rate of the hormone drugs up to 18.67%. 3) antifungal generic triazole drugs in the amount of sorting the top the voriconazole ranking increased from three in 2009 to 2011, a. 4) manufacturers ranked in the top few foreign companies accounted for the vast majority of domestic enterprises, such as of Zhuhai billion state in 2011 rose to 3. 5) The antifungal the DDDs sort of triazoles fluconazole and itraconazole is still the top row, shallow antifungal special terbinafine ranked top. Conclusion: 1) 2009 2011 Nanjing 33 hospitals antifungal medication the amount of growth is more significant anti deep fungal drugs tend to choose the triazoles, especially fluconazole and itraconazole, superficial fungal infection tends to use special than naphthalene fun, white spines neomycin drug usage growth, the most significant. 2) imported drugs accounted for the major markets, as the representative of the United States, Pfizer and Xian-Janssen. 3) the amount of sort and DDDs sort of slightly different reason may be that the triazole drug voriconazole high prices, that in DDDs sort at the back of terbinafine.[Key words] antifungal; drug use; amount; of DDD Nanjing热心网友 时间:2023-11-01 11:27
[Abstract] Objective: through to the Nanjing area in 33 hospitals from 2009 to 2011 antifungal drug use analysis of the situation in recent years, to the evaluation of antifungal agents in the treatment of.Methods: the sum and DDDs analysis and sorting method of drug utilization analysis.Results: 1) antifungal drugs accounted for total amount of antimicrobial drugs increased year by year, of which 2010 annual growth rate for the highest 16.9%.2) antifungal drug amount proportion is the largest deep antibacterial drugs, especially the three azole drugs, amount from 33605600 yuan in 2009 to 44184300 yuan in 2011, an average annual growth rate of 14.66%, spike kitasamycin drugs to a maximum of 18.67% average annual growth rate.3) antifungal drug generic name in order of the amount of three triazole drug at the front row, voriconazole ranking from 2009 third to 2011 first.4) manufacturers in the ranking, the first several foreign invested enterprises accounted for the vast majority, there are domestic enterprises such as Zhuhai billion to the 2011 rising to third.5) antifungal drug DDDs sort of three triazole, fluconazole and itraconazole is still ranked in the forefront, shallow antifungal terbinafine ranking top.Conclusion: 1) in Nanjing from 2009 to 2011 in 33 hospitals of antifungal drugs is more significant amount of growth, resistance to fungal drugs tend to choose three triazole, fluconazole and itraconazole in particular, superficial fungal infections tend to use of terbinafine, spines kitasamycin drugs utilization rate of growth is the most significant.2) imported drugs to occupy the main market in the United States, Pfizer and Yang Sen as the representative of xi'an.3) the amount of sequencing and DDDs ranking slightly different may be the cause of three triazole drug voriconazole price is on the high side, so that in the DDDs ranking ranked terbinafine behind.热心网友 时间:2023-11-01 11:28
[abstract] objective: to nanjing area by 33 hospitals in 2009 ~ 2011 years of antifungal drugs, by the analysis of the evaluation of antifungal drugs in recent years. Methods: the amount and drug use frequency analysis and sorting method for the drug use analysis. Results: 1) antifungal drugs to total antimicrobial agents in the amount of the trend has increased year by year, of which 2010 annual growth rate up to 16.9%. 2) antifungal drugs constitute the largest amount than deep antibiotic, especially three azole drug, amount by 2009 the $33.6056 million increase in 2011 to 44.1843 million yuan, with an average annual growth rate of 14.66%, with the white drugs maximum annual growth rate of 18.67%. 3) antifungal drugs amount of generic sorting of three azole drug the top, the ranking voriconazole from the third place in 2009 rose to 2011 in the first place. 4) manufacturer rankings, the first several of the foreign enterprise in a majority, also the domestic enterprise such as zhuhai nations to 2011 she rose to third place. 5) antifungal drugs DDDs sort, three azole fluconazole itraconazole and was still the top, shallow antifungal drugs than naphthalene, Stevens also ranked the first. Conclusion: 1) 2009 ~ 2011 nanjing area hospitals and antifungal medication amount growth is significant, resistance to deep fungus drugs tend to choose three azole, especially fluconazole and itraconazole thiazole, superficial fungal infections tend to use than naphthalene, Finn, with the white of drugs utilization rate is the most significant growth. 2) haart occupy the central market, by American Pfizer and xian-janssen represented. 3) order and the amount DDDs sort of slightly different reasons may be three azole voriconazole drug prices high, in order that DDDs were ranked than naphthalene, Finn behind.热心网友 时间:2023-11-01 11:28
[abstract] objective: to nanjing area by 33 hospitals in 2009 ~ 2011 years of antifungal drugs, by the analysis of the evaluation of antifungal drugs in recent years. Methods: the amount and drug use frequency analysis and sorting method for the drug use analysis. Results: 1) antifungal drugs to total antimicrobial agents in the amount of the trend has increased year by year, of which 2010 annual growth rate up to 16.9%. 2) antifungal drugs constitute the largest amount than deep antibiotic, especially three azole drug, amount by 2009 the $33.6056 million increase in 2011 to 44.1843 million yuan, with an average annual growth rate of 14.66%, with the white drugs maximum annual growth rate of 18.67%. 3) antifungal drugs amount of generic sorting of three azole drug the top, the ranking voriconazole from the third place in 2009 rose to 2011 in the first place. 4) manufacturer rankings, the first several of the foreign enterprise in a majority, also the domestic enterprise such as zhuhai nations to 2011 she rose to third place. 5) antifungal drugs DDDs sort, three azole fluconazole itraconazole and was still the top, shallow antifungal drugs than naphthalene, Stevens also ranked the first. Conclusion: 1) 2009 ~ 2011 nanjing area hospitals and antifungal medication amount growth is significant, resistance to deep fungus drugs tend to choose three azole, especially fluconazole and itraconazole thiazole, superficial fungal infections tend to use than naphthalene, Finn, with the white of drugs utilization rate is the most significant growth. 2) haart occupy the central market, by American Pfizer and xian-janssen represented. 3) order and the amount DDDs sort of slightly different reasons may be three azole voriconazole drug prices high, in order that DDDs were ranked than naphthalene, Finn behind.